Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis

BACKGROUND: Dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, optimal duration remains uncertain in some situations. We assessed the benefits and harms of extending DAPT beyond 1 year after PCI in clinically importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Jesse, Kelly, Shannon E., Bai, Zemin, Skidmore, Becky, Boucher, Michel, So, Derek, Wells, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911127/
https://www.ncbi.nlm.nih.gov/pubmed/36750248
http://dx.doi.org/10.9778/cmajo.20210119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911127/
https://www.ncbi.nlm.nih.gov/pubmed/36750248
http://dx.doi.org/10.9778/cmajo.20210119

Ejemplares similares